First Wave BioPharma, Inc. (FWBI) Financials
FWBI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 5.9 million | 2.6 million |
| 2023-06-30 | 4.3 million | 3.4 million |
| 2023-03-31 | 5.5 million | 2.8 million |
| 2022-12-31 | 5.4 million | 2.7 million |
FWBI Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -3.3 million | 263330 |
| 2023-06-30 | -2.8 million | 292704 |
| 2023-03-31 | -2.8 million | 358316 |
| 2022-12-31 | -5.6 million | 84346 |
FWBI Net Income
No data available :(
FWBI Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 3.3 million | - | 231292 |
| 2023-06-30 | 1.2 million | - | 248226 |
| 2023-03-31 | 2.1 million | - | 264460 |
| 2022-12-31 | 1.4 million | - | 280211 |
FWBI Shares Outstanding
FWBI Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 1.0 million | 2.4 million | - |
| 2023-06-30 | - | 1.4 million | 2.8 million | - |
| 2023-03-31 | - | 1.4 million | 2.7 million | - |
| 2022-12-31 | - | 101822 | 2.2 million | - |
FWBI Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 23413 |
| 2023-06-30 | - | 23125 |
| 2023-03-31 | - | 22846 |
| 2022-12-31 | - | 22573 |
FWBI
Price: $2.60
52 week price:
Earnings Per Share: 1131.40 USD
P/E Ratio: 0.00
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 308700
Market Capitalization: 8.1 million